全文获取类型
收费全文 | 2737篇 |
免费 | 118篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 87篇 |
妇产科学 | 11篇 |
基础医学 | 352篇 |
口腔科学 | 53篇 |
临床医学 | 149篇 |
内科学 | 754篇 |
皮肤病学 | 25篇 |
神经病学 | 234篇 |
特种医学 | 81篇 |
外科学 | 462篇 |
综合类 | 10篇 |
预防医学 | 52篇 |
眼科学 | 10篇 |
药学 | 229篇 |
中国医学 | 6篇 |
肿瘤学 | 332篇 |
出版年
2023年 | 19篇 |
2022年 | 13篇 |
2021年 | 55篇 |
2020年 | 19篇 |
2019年 | 47篇 |
2018年 | 54篇 |
2017年 | 38篇 |
2016年 | 52篇 |
2015年 | 54篇 |
2014年 | 77篇 |
2013年 | 101篇 |
2012年 | 125篇 |
2011年 | 140篇 |
2010年 | 90篇 |
2009年 | 80篇 |
2008年 | 161篇 |
2007年 | 152篇 |
2006年 | 150篇 |
2005年 | 158篇 |
2004年 | 177篇 |
2003年 | 179篇 |
2002年 | 181篇 |
2001年 | 44篇 |
2000年 | 27篇 |
1999年 | 37篇 |
1998年 | 48篇 |
1997年 | 31篇 |
1996年 | 34篇 |
1995年 | 22篇 |
1994年 | 58篇 |
1993年 | 53篇 |
1992年 | 46篇 |
1991年 | 29篇 |
1990年 | 32篇 |
1989年 | 28篇 |
1988年 | 29篇 |
1987年 | 26篇 |
1986年 | 21篇 |
1985年 | 18篇 |
1984年 | 14篇 |
1983年 | 9篇 |
1982年 | 19篇 |
1981年 | 15篇 |
1980年 | 20篇 |
1979年 | 10篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1973年 | 8篇 |
1972年 | 6篇 |
1969年 | 8篇 |
排序方式: 共有2867条查询结果,搜索用时 15 毫秒
1.
Tomoyasu Tachibana Shin Kariya Yoji Wani Yasutoshi Komatsubara Yuto Naoi Kazunori Kuroda Soichiro Fushimi Machiko Hotta Katsuya Haruna Tami Nagatani Takuma Makino Yuko Kataoka Kazunori Nishizaki 《Auris, nasus, larynx》2021,48(1):154-160
ObjectivesSialolipoma has been classified as a benign soft tissue lesion in the 2017 World Health Organization classification of head and neck tumors. To our knowledge, only one case of laryngeal sialolipoma has been reported in the English literature. We conducted a retrospective study to identify clinical characteristics of supraglottic sialolipoma-like lesion and differentiate it from other supraglottic subepithelial masses.MethodsMedical records of 16 patients with supraglottic subepithelial benign mass lesions who underwent histological evaluation between 2003 and 2019 were retrospectively analyzed. Sialolipoma-like lesion was defined as a local finding of a well-circumscribed gross mass with pathological presence of salivary gland-like parenchymal lobules with evenly interspersed adipose tissue.ResultsEight patients showed histological positivity for sialolipoma-like lesion, 3 for amyloidosis, 2 for hemangioma, and 1 each for cyst, lymphoid hyperplasia, and chondrometaplasia. Sialolipoma-like lesion tended to be predominant among men; those affected had a mean age of 52.8 (range, 39–74) years. By contrast, among patients with amyloidosis, the ratio of men to women was 1:2 (100% vs. 33%; p = 0.055). Fiberscopic examination of all patients with sialolipoma-like lesions identified well-circumscribed, yellowish masses, closely resembling local amyloidosis findings. Sialolipoma-like lesion was associated with a significantly higher body-mass index (BMI; 27.4 ± 2.8 kg/m2) than amyloidosis (21.6 ± 1.4 kg/m2; p = 0.014). The transoral approach was used for lesion resection in all patients with sialolipoma-like lesion. No patient experienced postoperative recurrence.ConclusionLaryngeal sialolipoma-like lesion might be more prevalent than was previously reported, and histological examination is important to differentiate it from amyloidosis. Supraglottic sialolipoma-like lesion must be differentially diagnosed in patients with high BMI presenting with well-circumscribed, yellowish supraglottic masses. 相似文献
2.
3.
Takuya Satomi Seiji Kawano Tomoki Inaba Masahiro Nakagawa Hirokazu Mouri Masao Yoshioka Shoichi Tanaka Tatsuya Toyokawa Sayo Kobayashi Takehiro Tanaka Hiromitsu Kanzaki Masaya Iwamuro Yoshiro Kawahara Hiroyuki Okada 《World journal of gastroenterology : WJG》2021,27(11):1043-1054
BACKGROUNDRecent improvements in the prognosis of patients with esophageal cancer have led to the increased occurrence of gastric tube cancer (GTC) in the reconstructed gastric tube. However, there are few reports on the treatment results of endoscopic submucosal dissection (ESD) for GTC.AIMTo evaluate the efficacy and safety of ESD for GTC after esophagectomy in a multicenter trial.METHODSWe retrospectively investigated 48 GTC lesions in 38 consecutive patients with GTC in the reconstructed gastric tube after esophagectomy who had undergone ESD between January 2005 and December 2019 at 8 institutions participating in the Okayama Gut Study group. The clinical indications of ESD for early gastric cancer were similarly applied for GTC after esophagectomy. ESD specimens were evaluated in 2-mm slices according to the Japanese Classification of Gastric Carcinoma with curability assessments divided into curative and non-curative resection based on the Gastric Cancer Treatment Guidelines. Patient characteristics, treatment results, clinical course, and treatment outcomes were analyzed.RESULTSThe median age of patients was 71.5 years (range, 57-84years), and there were 34 men and 4 women. The median observation period after ESD was 884 d (range, 8-4040 d). The median procedure time was 81 min (range, 29-334 min), the en bloc resection rate was 91.7% (44/48), and the curative resection rate was 79% (38/48). Complications during ESD were seen in 4% (2/48) of case, and those after ESD were seen in 10% (5/48) of case. The survival rate at 5 years was 59.5%. During the observation period after ESD, 10 patients died of other diseases. Although there were differences in the procedure time between institutions, a multivariate analysis showed that tumor size was the only factor associated with prolonged procedure time.CONCLUSIONESD for GTC after esophagectomy was shown to be safe and effective. 相似文献
4.
5.
Shuhei Nakanishi Masashi Shimoda Fuminori Tatsumi Kenji Kohara Atsushi Obata Junpei Sanada Yoshiro Fushimi Tomoatsu Mune Kohei Kaku Hideaki Kaneto 《Journal of diabetes investigation.》2021,12(12):2259-2262
This study examined the association between Grit Scales and adherence to a schedule of regular hospital visits among Japanese type 2 diabetes patients. Patients with type 2 diabetes who visited the outpatient clinic as new patients comprised the study’s participants. Self-administered Short Grit Scale data were obtained from 122 patients at the first consultation and were then observed for 1 year. As the results, 21 participants failed to attend the hospital. In a logistic regression analysis, the Grit Scale as a continuous variable was positively associated with adherence to regular clinical visits. Its odds ratio and 95% confidential interval was 9.68 and 2.87–32.65 (P = 0.0003). In conclusion, it is likely that the Grit Scale is closely associated with adherence to regular hospital visits among Japanese type 2 diabetes patients. 相似文献
6.
7.
8.
9.
Masaya Koshizaka MD Ko Ishikawa MD Ryoichi Ishibashi MD Yoshiro Maezawa MD Kenichi Sakamoto MD Daigaku Uchida MD Susumu Nakamura MD Masaya Yamaga MD Hidetaka Yokoh MD Akina Kobayashi MD Shunichiro Onishi MD Kazuki Kobayashi MD Jun Ogino MD Naotake Hashimoto MD Hirotake Tokuyama MD Fumio Shimada MD Emi Ohara MD Takahiro Ishikawa MD Mayumi Shoji MD Shintaro Ide MD Kana Ide MD Yusuke Baba MD Akiko Hattori MD Takumi Kitamoto MD Takuro Horikoshi MD Ryota Shimofusa MD Sho Takahashi PhD Kengo Nagashima PhD Yasunori Sato PhD Minoru Takemoto MD Laura Kristin Newby MD Koutaro Yokote MD On Behalf of the PRIME-V Study Group 《Diabetes, obesity & metabolism》2019,21(8):1990-1995
A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study was conducted to evaluate the efficacy of treatment with ipragliflozin (sodium-dependent glucose transporter-2 inhibitor) versus metformin for visceral fat reduction and glycaemic control among Japanese patients with type 2 diabetes treated with sitagliptin, HbA1c levels of 7%-10%, and body mass index (BMI) ≥ 22 kg/m2. Patients were randomly assigned (1:1) to receive ipragliflozin 50 mg or metformin 1000-1500 mg daily. The primary outcome was change in visceral fat area as measured by computed tomography after 24 weeks of therapy. The secondary outcomes were effects on glucose metabolism and lipid metabolism. Mean percentage reduction in visceral fat area was significantly greater in the ipragliflozin group than in the metformin group (−12.06% vs. −3.65%, P = 0.040). Ipragliflozin also significantly reduced BMI, subcutaneous fat area, waist circumference, fasting insulin, and homeostatic model assessment (HOMA)-resistance, and increased HDL-cholesterol levels. Metformin significantly reduced HbA1c and LDL-cholesterol levels and increased HOMA-beta. There were no severe adverse events. The use of ipragliflozin or metformin in combination with dipeptidyl peptidase-4 inhibitors, widely used in Japan, may have beneficial effects in ameliorating multiple cardiovascular risk factors. 相似文献
10.
Shuhei Nakanishi Masahiro Iwamoto Hidenori Hirukawa Masashi Shimoda Fuminori Tatsumi Kenji Kohara Atsushi Obata Seizo Okauchi Tomoe Kinoshita Junpei Sanada Yoshiro Fushimi Momoyo Nishioka Akiko Mizoguchi Miyuki Kameyama Tomoatsu Mune Kohei Kaku Hideaki Kaneto 《Journal of diabetes investigation.》2019,10(1):104-107
We retrospectively evaluated the effects of mild physical exercise (P) in a routine clinical setting on glycemic and bodyweight control in Japanese type 2 diabetes patients with and without individualized nutritional therapy (D). We analyzed 49 patients who participated in P that measured 2.5 metabolic equivalents and was held once every 2 weeks, compared with 83 non‐participant controls, followed over a period of approximately 1.6 years. With a Cox model, the adjusted hazard ratio for improved glycated hemoglobin by numerical count of P was 1.03 (95% confidence interval [CI] 1.00–1.07; P = 0.025). Among four categories – with neither P nor D, only P, only D, and both P and D – the hazard ratios for reduced body mass index were 1.0, 0.87 (95% CI 0.46–1.67), 0.58 (95% CI 0.25–1.30) and 2.17 (95% CI 1.03–4.59), respectively. Even mild physical exercise contributed to glycemic control. The combination of P and D exerted beneficial effects on bodyweight control. 相似文献